...
首页> 外文期刊>The biochemical journal >Purification of A1 adenosine receptor–G-protein complexes: effects of receptor down-regulation and phosphorylation on coupling
【24h】

Purification of A1 adenosine receptor–G-protein complexes: effects of receptor down-regulation and phosphorylation on coupling

机译:A1腺苷受体-G蛋白复合物的纯化:受体下调和磷酸化对偶联的影响

获取原文
           

摘要

pWe examined the effects of exposing Asub1/sub adenosine receptors (Asub1/subARs) to an agonist on the stability and phosphorylation state of receptor–guanine nucleotide-binding regulatory protein (R–G-protein) complexes. Non-denatured recombinant human Asub1/subARs extended on the N-terminus with hexahistidine (Hissub6/sub) and the FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) epitope (H/F) were purified to near homogeneity from stably transfected Chinese-hamster ovary (CHO)-K1 cells. Purified receptors have pharmacological properties similar to receptors in membranes. G-proteins were co-purified with 15±2% of H/F-Asub1/subAR unless receptor–G-protein (R–G) complexes were uncoupled by pre-treating cell membranes with GTP. By silver staining, purified Asub1/subAR–G-protein complexes contain receptors, G-protein α and β subunits and an unidentified 97 kDa protein. Pretreating intact cells with iN/isup6/sup-cyclopentyladenosine (CPA) for 24 h decreased both the total number of receptors measured in membranes and the number of purified Asub1/subARs by about 50%. In contrast, pretreating cells with CPA decreased the number of R–G complexes measured in membranes (54±6%) significantly less than it decreased the number of purified R–G complexes (78±3%) as detected by sup125/supI-iN/isup6/sup-(4-aminobenzyl)adenosine binding or by Western blotting Gsubi/subα2. The effect of CPA to decrease the fraction of receptors purified as R–G complexes was not associated with any change in low-level Asub1/subAR phosphorylation (found on serine), or low-level phosphorylation of G-protein α or β subunits or the 97 kDa protein. These experiments reveal a novel aspect of agonist-induced down-regulation, namely a diminished stability of receptor–G-protein complexes that is manifested as uncoupling during receptor purification./p
机译:>我们研究了将A 1 腺苷受体(A 1 ARs)暴露于激动剂对受体-鸟嘌呤核苷酸结合调节蛋白的稳定性和磷酸化状态的影响(RG蛋白)复合物。非变性的重组人A 1 ARs在N末端延伸有六组氨酸(His 6 )和FLAG(Asp-Tyr-Lys-Asp-Asp-Asp-从稳定转染的中国仓鼠卵巢(CHO)-K1细胞中纯化Asp-Lys)表位(H / F)至近乎同质。纯化的受体具有类似于膜受体的药理特性。除非通过GTP预处理细胞膜使受体-G蛋白(R-G)复合物解偶联,否则G-蛋白会与15±2%的H / F-A 1 AR共纯化。通过银染,纯化的A 1 AR–G蛋白复合物包含受体,G蛋白α和β亚基以及一个未知的97kDa蛋白。用 N 6 -环戊基腺苷(CPA)预处理完整细胞24小时可减少膜中测量的受体总数和纯化的A 1 < / sub> ARs约50%。相比之下,用CPA预处理的细胞减少了在膜中测得的R–G复合物的数量(54±6%),远小于其减少纯化的R–G复合物的数量(78±3%)的数量,由 125检测到 I- N 6 -(4-氨基苄基)腺苷结合或通过蛋白质印迹G i α2。 CPA降低纯化为R–G复合物的受体比例的作用与低水平A 1 AR磷酸化(丝氨酸上发现)或G的低水平磷酸化没有任何关系-蛋白α或β亚基或97kDa蛋白。这些实验揭示了激动剂诱导的下调的一个新方面,即受体-G蛋白复合物的稳定性降低,这在受体纯化过程中表现为解偶联。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号